Insider Activity of Yeleswaram Krishnaswamy
According to the SEC Form 4 filings, Yeleswaram Krishnaswamy, being in a position of
- Chief Development Officer at Rapport Therapeutics, Inc. Common Stock,оver the last 12 months, has bought 0 shares, and sold 103969 shares for $4.46M,over all time since 2025-12-31, has bought 0 shares, and sold 103969 shares for $4.46M.
Biography of Yeleswaram Krishnaswamy
No biography is available at this moment.